PHARMACOR ESOMEPRAZOLE esomeprazole magnesium dihydrate 40 mg enteric coated blister pack

Ország: Ausztrália

Nyelv: angol

Forrás: Department of Health (Therapeutic Goods Administration)

Aktív összetevők:

esomeprazole magnesium dihydrate

Beszerezhető a:

Medis Pharma Pty Ltd

INN (nemzetközi neve):

esomeprazole magnesium dihydrate

Engedélyezési státusz:

Registered

Betegtájékoztató

Pharmacor Pty. Ltd.
Version 01
1
PHARMACOR ESOMEPRAZOLE
ESOMEPRAZOLE
MAGNESIUM DIHYDRATE_ _
(ES-oh-MEP-ra-zole) -
enteric coated tablets
_ _
CONSUMER MEDICINE INFORMATION
_ _
WHAT IS IN THIS
LEAFLET
This leaflet answers some of the
common questions people ask about
PHARMACOR ESOMEPRAZOLE. It
does not contain all the information
that is known about PHARMACOR
ESOMEPRAZOLE.
It does not take the place of talking to
your doctor or pharmacist.
All medicines have risks and benefits.
Your doctor will have weighed the
risks of you taking PHARMACOR
ESOMEPRAZOLE against the benefits
they expect it will have for you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, ASK YOUR DOCTOR
OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again
.
WHAT PHARMACOR
ESOMEPRAZOLE IS
USED FOR
_REFLUX OESOPHAGITIS _
_ _
PHARMACOR ESOMEPRAZOLE is
taken to treat reflux oesophagitis. This
can be caused by "washing back"
(reflux) of food and acid from the
stomach into the food pipe
(oesophagus).
Reflux can cause a burning sensation
in the chest rising up to the throat,
also known as heartburn.
PHARMACOR ESOMEPRAZOLE is
also taken to help stop reflux
oesophagitis coming back or relapsing.
_ _
_ _
_UPPER GASTROINTESTINAL SYMPTOMS _
_ASSOCIATED WITH NON-STEROIDAL ANTI-_
_INFLAMMATORY DRUGS (NSAIDS) _
_THERAPY _
_ _
PHARMACOR ESOMEPRAZOLE is
taken to treat the symptoms of pain or
discomfort, in the stomach caused by
NSAIDs, a type of medicine for pain or
inflammation.
PHARMACOR ESOMEPRAZOLE is
also taken to help heal and prevent
ulcers caused by NSAIDs.
_PEPTIC ULCERS ASSOCIATED _
_WITH HELICOBACTER PYLORI _
_INFECTION _
_ _
Most people who have a peptic
(gastric and duodenal) ulcer also
have a bacterium called
_Helicobacter _
_pylori_
in their stomach.
Depending on the position of the
ulcer it is called a gastric or duodenal
ulcer. A gastric ulcer occurs in the
stomach. A duodenal ulcer occurs in
the duodenum which is the tube
leading out from the stomach.
If you have a peptic ulcer, your
doctor will prescribe PHARMACO

Termékjellemzők

PHARMACOR ESOMEPRAZOLE PI V3 JULY 2021
Page
1
of
30
AUSTRALIAN PRODUCT INFORMATION- PHARMACOR
ESOMEPRAZOLE (ESOMEPRAZOLE (AS MAGNESIUM DIHYDRATE)) ENTERIC-COATED
TABLET
1.
NAME OF THE MEDICINE
Esomeprazole (as magnesium dihydrate)
2.
QUANTITATIVE AND QUALITATIVE COMPOSITION
The PHARMACOR ESOMEPRAZOLE 20 mg and 40 mg tablet are enteric coated
and contain esomeprazole (as magnesium dihydrate).
PHARMACOR ESOMEPRAZOLE 20 mg tablet: Each enteric-coated tablet
contains
esomeprazole magnesium dihydrate 21.75 mg (equal to 20 mg
esomeprazole).
PHARMACOR ESOMEPRAZOLE 40 mg tablet: Each enteric-coated tablet
contains
esomeprazole magnesium dihydrate 43.50 mg (equal to 40 mg
esomeprazole).
For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS.
3.
PHARMACEUTICAL FORM
PHARMACOR ESOMEPRAZOLE 20 mg tablet: light pink, elliptically shaped,
biconvex, enteric coated tablet. Each enteric-coated tablet contains
esomeprazole
magnesium dihydrate 21.75 mg (equal to 20 mg esomeprazole).
PHARMACOR ESOMEPRAZOLE 40 mg tablet: pink, elliptically shaped,
biconvex,
enteric-coated tablet. Each enteric-coated tablet contains
esomeprazole magnesium
dihydrate 43.50 mg (equal to 40 mg esomeprazole).
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
PHARMACOR ESOMEPRAZOLE is indicated for:
GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
•
treatment of erosive reflux oesophagitis
•
long-term management of patients with healed oesophagitis to prevent
relapse
•
symptomatic treatment of gastro-oesophageal reflux disease (GORD)
PATIENTS REQUIRING NSAID THERAPY
•
short-term treatment of upper gastrointestinal symptoms associated
with non-
steroidal anti-inflammatory drug NSAID (non-selective and COX-2
selective)
therapy.
PHARMACOR ESOMEPRAZOLE PI V3 JULY 2021
Page
2
of
30
•
healing of gastric ulcers associated with non-steroidal
anti-inflammatory
drug NSAID (non-selective and COX-2 selective) therapy
•
prevention of gastric and duodenal ulcers associated with
non-steroidal anti
inflammatory drug NSAID (non-selective and COX-2 selectiv